Publicatie

Publicatie datum

CAPPA: Care for prostate cancer patients.

Heins, M.J., Korevaar, J.C., Rijken, P.M., Donker, G.A., Dulmen, A.M. van, Schellevis, F.G. CAPPA: Care for prostate cancer patients. Abstract. In: Abstract book 8th meeting of Ca-PRI 'The escalating cancer challenge - essential roles for primary care', 20-22 mei 2015, Aarhus. 38
Lees online
Background
More than half of the patients diagnosed with prostate cancer is aged over 65 and many of them suffer from comorbid chronic diseases. Several care providers are involved in the care for these patients. Therefore, a patient‐centred approach that goes beyond the disease is needed.

Research question
The objective of CAPPA is to implement and evaluate a new clinical pathway in primary care for older patients with prostate cancer and complex health care problems.

Methods
In this pilot study, we aimed to include 20 prostate cancer patients aged over 65 who are not under active treatment and have at least one concomitant chronic disease. Aftercare for prostate cancer will be transferred from the urologist to the GP for 12 months. To support GPs in the care for these patients, urologists and GPs jointly developed a care protocol and we provide GPs with the option of video consultation with a urologist, either alone or together with the patient.

Results
Within the 6 participating GP practices, 29 prostate cancer patients aged over 65 were eligible for participation. When contacted by a research nurse, 4 were not interested, 25 agreed to receive information and 21 (72%) ultimately gave informed consent. Patient satisfaction will be assessed at 6 and 12 months using questionnaires. In addition, both patients, GPs and urologists will be interviewed about their experiences after 12 months.

Discussion/Conclusion
Patients, urologists and GPs are interested in the new clinical pathway. In the coming year we will monitor their experiences. A successful clinical pathway will be assessed through the following criteria:
1) GPs do not refer patients to the urologist (unless for recurrence/metastasis).
2) The majority of the patients is satisfied.
3) The participating GPs and urologists are satisfied. When successful, the pathway can be implemented in other hospitals.
Gegevensverzameling